T.Rx Capital Fund I | 2023 VC Fund

T.Rx Capital

cb Email

Status

ACTIVE

Global HQ

Boston, United States

Countries of investment

United States
United Kingdom
Germany
Switzerland

Investment stages

Seed
Series A

Industries

Healthcare
Biotech

About
T.Rx Capital is a specialized venture capital firm that invests in and supports early-stage healthcare companies. As a physician-led fund, their mission is to leverage deep clinical and operational expertise to back founders who are transforming the way healthcare is delivered.

Min check size: $2M
Max check size: $10M
Fund size: Unlock
NPS: Unlock

Investment Thesis

T.Rx Capital is a physician-led venture capital firm that invests in early-stage healthcare companies aiming to transform care delivery. Their investment philosophy centers on leveraging the deep domain expertise and vast network of their team, which consists of physicians, scientists, and operators. They focus on the broad healthcare sector, providing hands-on support to help their portfolio companies navigate the complex industry and achieve success.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

The managing partners combine deep scientific, entrepreneurial, and executive leadership experience. Omri Amirav-Drory is a founder (Genome Compiler) and former partner at Playground Global, with a Ph.D. in biochemistry. Paul M. Meister brings extensive executive experience, having served as President of MacAndrews & Forbes and CEO of inVentiv Health, with a strong background in finance and board leadership.